Xphyto Therapetutics

XPhyto Therapeutics (XPHY.C) announced today that it has signed a master supply agreement with Beovita GmhB and Tackleberries GmbH, two German diagnostics, testing and medical logistics companies. Cumulatively, both…
XPhyto Therapeutics (XPHY.C), a bioscience accelerator in the life science industry, announced today that its drug formulation programs are advancing on schedule and continue to expand in scope. “Vektor…
XPhyto Therapeutics (XPHY.C) announced they are beginning a pilot project with their rapid Covid-19 PCR test (Covid-ID Lab) in a point-of-care (POC) setting in Germany. The Covid-ID Lab test…
Xphyto Therapeutics’ (XPHY.C) subsidiary Vektor Pharma TF GmbH has finished work on their oral disintegrating film (ODF), a dosage formulation for a major European pharma-company and is now ready…